MAIA Biotechnology, Inc.
Company Information
Industry
Pharmaceutical Preparations
SIC Code
2834
Entity Type
operating
SEC Category
Emerging growth company
State of Incorporation
DE
Business Address
444 WEST LAKE STREET, SUITE 1700, CHICAGO, IL, 60606
Mailing Address
444 WEST LAKE STREET, SUITE 1700, CHICAGO, IL, 60606
Phone
312-416-8592
Fiscal Year End
1231
EIN
000000000
Financial Overview
FY2025
-$22.40M
Net Income
$10.16M
Total Assets
-
Cash & Equivalents
$-0.70
EPS
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| 8-K Current report of material events | March 31, 2026 | View on SEC |
| 8-K Current report of material events | March 27, 2026 | View on SEC |
| 10-K Annual financial report | March 23, 2026 | View on SEC |
| 424B5 Prospectus supplement | March 4, 2026 | View on SEC |
| 8-K Current report of material events | March 4, 2026 | View on SEC |
| 424B5 Prospectus supplement | March 2, 2026 | View on SEC |
| 8-K Current report of material events | February 24, 2026 | View on SEC |
| 8-K Current report of material events | January 20, 2026 | View on SEC |
| 8-K Current report of material events | January 13, 2026 | View on SEC |
| 4 Insider stock transaction report | January 12, 2026 | View on SEC |
Annual Reports
10-K
March 23, 2026
- MAIA successfully raised $24.4 million in 2024 through diverse funding strategies to advance its drug pipeline, especially THIO.
- The company maintains financial flexibility with an At-The-Market (ATM) program, with $21.3 million remaining available for future capital raises.
Insider Trading
STRONG BUY
5 insiders
20 recent transactions
View Full Insider Trading Profile
Related Companies
Companies in the same industry (SIC: 2834)
NERVGEN PHARMA CORP.
NGEN
Pharmaceutical Preparations
Connect Biopharma Holdings Ltd
CNTB
Pharmaceutical Preparations
LIXTE BIOTECHNOLOGY HOLDINGS, INC.
LIXT
Pharmaceutical Preparations
TuHURA Biosciences, Inc./NV
HURA
Pharmaceutical Preparations
Canton Strategic Holdings, Inc.
CNTN
Pharmaceutical Preparations
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.